P/E ratio for Cassava Sciences (SAVA)
P/E ratio as of April 2024 (TTM): -9.68
According to Cassava Sciences 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -9.6758. At the end of 2022 the company had a P/E ratio of -15.5.
P/E ratio history for Cassava Sciences from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -15.5 | -71.18% |
| 2021 | -54.0 | 97.77% |
| 2020 | -27.3 | 36.4% |
| 2019 | -20.0 | 1876.47% |
| 2018 | -1.01 | -53.71% |
| 2017 | -2.19 | 30.38% |
| 2016 | -1.68 | -70.3% |
| 2015 | -5.65 | -22.14% |
| 2014 | -7.25 | -202.93% |
| 2013 | 7.04 | -118.77% |
| 2012 | -37.5 | -40.76% |
| 2011 | -63.3 | 153.33% |
| 2010 | -25.0 | -67.35% |
| 2009 | -76.6 | -578.57% |
| 2008 | 16.0 | -30.57% |
| 2007 | 23.0 | -63.75% |
| 2006 | 63.6 | -758.28% |
| 2005 | -9.66 | 36.62% |
| 2004 | -7.07 | -25.75% |
| 2003 | -9.52 | 135.03% |
| 2002 | -4.05 | -75.23% |
| 2001 | -16.4 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -4.36 | -54.91% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.